Sirkku Peltonen
sipelto@utu.fi Kiinamyllynkatu 4-8 Turku |
- The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland (2023)
- European Journal of Human Genetics
- Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma (2022)
- Cancers
- Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1 (2022)
- Dermatology
- The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: evidence from Finland (2022)
- Genetics in Medicine
- Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience (2022)
- European Journal of Medical Genetics
- Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis (2022)
- Journal of Allergy and Clinical Immunology
- A rare disease and education: Neurofibromatosis type 1 decreases educational attainment (2021)
- Clinical Genetics
- Circulating free DNA in the plasma of individuals with neurofibromatosis type 1 (2021)
- American Journal of Medical Genetics Part A
- Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries (2021)
- Nature Communications
- Haploinsufficiency of the NF1 gene is associated with protection against diabetes (2021)
- Journal of Medical Genetics



